Volume : 08, Issue : 07, July – 2021
Title:
14.NANOPARTICLES AND LIPOSOMES PAVING A WAY FOR
SMART DRUG DELIVERY SYSTEM
Authors :
Hindavi C. Deshmane, Saurav S. Kawale, Saiee P. Joshi, Kaustubh A. Kasture, Prashant L. Pingale*
Abstract :
There are exponential developments in nanotechnology and its medical applications over the past few years, traditional drug delivery systems have been encompassed in smart, stimulus-responsive drug delivery systems. Using the reaction to particular stimuli, known nano-platforms may improve the effectiveness of drug targeting by minimising side effects and the toxicity of payload, which are important factors to enhance patient conformity. Various advanced drug delivery systems are widely used for various interesting structures, such as stimuli-triggered nanoparticles, liposomes. However, these nano-programmes do not have a standardised manufacturing process, toxicity evaluation expertise and clear applicable significance between pre-clinical (diagnostic) and therapeutic studies.
A smart drug delivery system (SDDS), a newly developing therapeutic method, is now becoming a traditional drug delivery prototype for particular locations or targets. Drug-targeted delivery (DT) systems sustain the concentration of drugs at required doses in the human body and reduce the necessity for frequent doses. The DT system has some unique features like self-regulation, pre-programming, multi-targeted, timely response control, mapping of targeted drug delivery, response to pH, and spatial targeting. The DT system uses biological membrane modifications in the structure of malicious cells to improve the incorporation or entry of drug-coated nanoparticles into targeted tissues. This device provides a certain amount of the medicinal substance for the longevity of its operation to a targeted region within the human tissue; this increases the effectiveness of the procedure by decreasing the side effects of the drug.
Keywords: Smart Drug Delivery System, Microelectromechanical systems, Nanoelectromechanical systems, Nano-carriers, Liposomes.
Cite This Article:
Please cite this article in press Prashant L. Pingale et al., Nanoparticles and liposomes paving a way for Smart drug delivery system.., Indo Am. J. P. Sci, 2021; 08(07).
Number of Downloads : 10
References:
1. Liu D, Yang F, Xiong F, Gu N. The smart drug delivery system and its clinical potential. Theranostics. 2016; 6(9):1306-1323.
2. Dhanasekaran S, Chopra S. Getting a Handle on Smart Drug Delivery Systems–A Comprehensive View of Therapeutic Targeting Strategies. Smart drug delivery system. InTech, Croatia. 2016:31-62.
3. Pierigè F, Serafini S, Rossi L, Magnani M. Cell-based drug delivery. Advanced Drug Delivery Reviews. 2008; 60(2):286-295.
4. Schmidt JJ, Rowley J, Kong HJ. Hydrogels used for cell‐based drug delivery. Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials. 2008; 87(4):1113-1122.
5. Walker PA, Aroom KR, Jimenez F, Shah SK, Harting MT, Gill BS, Cox CS. Advances in progenitor cell therapy using scaffolding constructs for central nervous system injury. Stem Cell Reviews and Reports. 2009; 5(3):283-300.
6. Hossen S, Hossain MK, Basher MK, Mia MN, Rahman MT, Uddin MJ. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. Journal of Advanced Research. 2019; 15:1-8.
7. Liu J, Huang Y, Kumar A, Tan A, Jin S, Mozhi A, Liang XJ. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnology Advances. 2014; 32(4):693-710.
8. Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, Zhang P, Yang X, Cui H, Li Y. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Acta Biomaterialia. 2015; 14:115-124.
9. Gao W, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Molecular Pharmaceutics. 2010; 7(6):1913-1920.
10. Subudhi MB, Jain A, Jain A, Hurkat P, Shilpi S, Gulbake A, Jain SK. Eudragit S100 coated citrus pectin nanoparticles for colon targeting of 5-fluorouracil. Materials. 2015; 8(3):832-849.
11. Stubbs M, McSheehy PM, Griffiths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Molecular Medicine Today. 2000; 6(1):15-19.
12. Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nature Reviews Drug discovery. 2011; 10(10):767-777.
13. Lee ES, Oh KT, Kim D, Youn YS, Bae YH. Tumor pH-responsive flower-like micelles of poly (L-lactic acid)-b-poly (ethylene glycol)-b-poly (L-histidine). Journal of Controlled Release. 2007; 123(1):19-26.
14. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. Journal of Controlled Release. 2010; 148(2):135-146.
15. Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature Reviews Drug Discovery. 2014; 13(11):813-827.
16. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature Materials. 2013; 12(11):991-1003.
17. Lal S, Clare SE, Halas NJ. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Accounts of Chemical Research. 2008; 41(12):1842-1851.
18. De La Rica R, Aili D, Stevens MM. Enzyme-responsive nanoparticles for drug release and diagnostics. Advanced Drug Delivery Reviews. 2012; 64(11):967-978.
19. Shen N, Lei B, Wang Y, Xu S, Liu H. Redox/ultrasound dual stimuli-responsive nanogel for precisely controllable drug release. New Journal of Chemistry. 2018; 42(12):9472-9481.
20. Weissig V, Pettinger TK, Murdock N. Nanopharmaceuticals (part 1): products on the market. International Journal of Nanomedicine. 2014; 9:4357-4373.
21. Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today. 2014; 9(2):223-243.
22. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K. Liposome: classification, preparation, and applications. Nanoscale Research Letters. 2013; 8(1):1-9.
23. Nimtrakul P, Williams DB, Tiyaboonchai W, Prestidge CA. Copolymeric Micelles Overcome the Oral Delivery Challenges of Amphotericin B. Pharmaceuticals. 2020; 13(6):121.
24. Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017; 9(2):12.
25. Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. Application of liposomes in medicine and drug delivery. Artificial Cells, Nanomedicine, and Biotechnology. 2016; 44(1):381-391.
26. Makwana V, Karanjia J, Haselhorst T, Anoopkumar-Dukie S, Rudrawar S. Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization. International Journal of Pharmaceutics. 2020:120117.
27. Olusanya TO, Haj Ahmad RR, Ibegbu DM, Smith JR, Elkordy AA. Liposomal drug delivery systems and anticancer drugs. Molecules. 2018; 23(4):907.
28. Douer D. Efficacy and safety of vincristine sulfate liposome injection in the treatment of adult acute lymphocytic leukemia. The oncologist. 2016; 21(7):840.
29. Salehi B, Selamoglu Z, S Mileski K, Pezzani R, Redaelli M, C Cho W, Kobarfard F, Rajabi S, Martorell M, Kumar P, Martins N. Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine. Biomolecules. 2019; 9(12):773.
30. Wei C, Li X. The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor. Frontiers in Pharmacology. 2020; 11:1626.
31. Villarruel Mendoza LA, Scilletta NA, Bellino MG, Desimone MF, Catalano PN. Recent advances in micro-electro-mechanical devices for controlled drug release applications. Frontiers in Bioengineering and Biotechnology. 2020; 8:827.